This is in sharp contrast to the impressive response to blockade of CTLA-4, PD-1, and PD-L1 seen in a broad variety of cancers of different origin [43], and strengthens the suggestion of the requirement for a relevant expression level of checkpoints on T cells. The gene discussed is CTLA4; the disease is cancer.